What are you
looking for?

Media

Media Release May 07, 2026
Siegfried included in Dow Jones Best-in-Class Europe Index
Media Release Apr 29, 2026
Siegfried DINAMIQS receives Swissmedic license for viral vector manufacturing
Ad hoc
Media Release Apr 24, 2026
Siegfried obtains antitrust clearance for acquisition of three drug substances sites in the US and Australia
Media Release Apr 16, 2026
Siegfried shareholders approve all proposals at Annual General Meeting 2026
Ad hoc
Media Release Feb 20, 2026
Siegfried delivers strong profitability and continued growth
Ad hoc
Media Release Feb 05, 2026
Changes to Siegfried’s Board of Directors
Ad hoc
Media Release Jan 27, 2026
Siegfried to acquire high-quality small molecules drug substance capacity in the US
Ad hoc
Media Release Nov 17, 2025
Siegfried announces Chief Financial Officer transition
Media Release Sep 29, 2025
DINAMIQS opens cGMP manufacturing facility for viral vectors
Ad hoc
Media Release Sep 26, 2025
Change in the Chairmanship of the Board of Directors
Media Release Sep 11, 2025
Siegfried successfully places senior bonds of CHF 300 million
Ad hoc
Media Release Aug 21, 2025
Siegfried on track to deliver profitable growth

Contact

Let's get in touch

Peter Stierli
Head Corporate Communications
To top